LAUSR

We report the synthesis, characterisation, and anti‐breast cancer stem cell (CSC) properties of two copper(II)‐terpyridine complexes with bidentate salicylaldehyde moieties (2‐hydroxybenzaldehyde for 1 and 2‐hydroxy‐1‐naphthaldehyde for 2). The copper(II)‐terpyridine complexes 1 and 2 are stable in biologically relevant aqueous solutions and display micromolar potency towards breast CSCs. The most effective complex 1 is 5‐fold and 6.6‐fold more potent towards breast CSCs than salinomycin and cisplatin, respectively. The copper(II)‐terpyridine complexes 1 and 2 also decrease the formation and viability of three‐dimensionally cultured mammospheres within the micromolar range. Notably complex 1 is up to 7‐fold more potent towards mammospheres than salinomycin or cisplatin. Mechanistic studies suggest that the copper(II)‐terpyridine complexes 1 and 2 are able to readily enter breast CSCs, elevate intracellular reactive oxygen species levels, induce DNA damage (presumably by oxidative DNA cleavage), and evoke apoptosis that is independent of caspases. This study shows that the copper(II)‐terpyridine motif is a useful building block for the design of anti‐breast CSC agents and reinforces the therapeutic potential of copper coordination complexes.